Dex Liquidating Co (Dex Liquidating Co) Risk Assessment

View and export this data going back to 2006. Start your Free Trial

What is Dex Liquidating Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Dex Liquidating Co is: No Data: Cannot be evaluated.

Competitive Comparison of Dex Liquidating Co's Risk Assessment

For the Shell Companies subindustry, Dex Liquidating Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dex Liquidating Co's Risk Assessment Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Dex Liquidating Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Dex Liquidating Co's Risk Assessment falls into.

Dex Liquidating Co (OTCPK:DXTRQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Dex Liquidating Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Dex Liquidating Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Dex Liquidating Co (Dex Liquidating Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Dex Liquidating Co (OTCPK:DXTRQ) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 West 41st Avenue, Suite 245, San Mateo, CA, USA, 94403

Website

https://www.dexliquidatingco.com

Dex Liquidating Co currently has no business operations.

Executives

Younger William H Jr	other: Former Director	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Newell Robert Y Iv	officer: V.P., Finance, CFO, Secretary	2309 BERING DRIVE, SAN JOSE CA 95131
Liam Burns	officer: VP,Worldwide Sales & Marketing	C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025
Gregory D Casciaro	director	361 RAQUEL LANE, LOS ALTOS CA 94022
Samuel E Navarro	director	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044
Richard M Ferrari	10 percent owner, other: See Explanation of Responses	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Broadfin Healthcare Master Fund Ltd	10 percent owner, other: See Explanation of Responses	C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Broadfin Capital, Llc	10 percent owner, other: See Explanation of Responses	300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Kevin Kotler	10 percent owner, other: See Explanation of Responses	C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Gary S Petersmeyer	director	3400 CENTRAL AVENUE, SANTA CLARA CA 95051
James C Gaither	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Baker G Leonard Jr	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Tench Coxe	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Pullara Samuel J Iii	10 percent owner	755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Hill Ventures Sutter	10 percent owner	755 PAGE MILL RD, SUITE A200, PALO ALTO CA 94304